Biotin-responsive basal ganglia disease maps to 2q36.3 and is due to mutations in SLC19A3.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  American Journal of Human Genetics

• Publication date

  2005-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1086/431216PMID 15871139PMCID PMC1226189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Wilson's disease: MRI demonstration of cavitations in basal ganglia and thalami

  2005cited by this paper
• Biotin deficiency reduces expression of SLC19A3, a potential biotin transporter, in leukocytes from human blood.

  2005cited by this paper
• Infantile bilateral striatal necrosis maps to chromosome 19q

  2004cited by this paper
• Novel mutation in the SLC19A2 gene in an African‐American female with thiamine‐responsive megaloblastic anemia syndrome

  2004cited by this paper
• Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine.

  2004cited by this paper
• Regulation of gene expression by biotin (review).

  2003cited by this paper
• Online Mendelian Inheritance in Man 'OMIM'.

  2003cited by this paper
• Biotin in metabolism and molecular biology.

  2002cited by this paper
• Lack of Plasma Membrane Targeting of a G172D Mutant Thiamine Transporter Derived from Rogers Syndrome Family

  2002cited by this paper
• Familial infantile bilateral striatal necrosis: Clinical features and response to biotin treatment

  2002cited by this paper
• Functional role of specific amino acid residues in human thiamine transporter SLC19A2: mutational analysis.

  2002cited by this paper
• The HMMTOP transmembrane topology prediction server

  2001influential reference
• A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine‐responsive megaloblastic anaemia, diabetes and deafness syndrome

  2001cited by this paper
• SLC19A3 encodes a second thiamine transporter ThTr2.

  2001cited by this paper
• Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes.

  2000cited by this paper
• A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I

  2000cited by this paper
• Bilateral striatal necrosis associated with Mycoplasma pneumoniae infection in an adolescent: Clinical and neuroradiologic follow up

  2000cited by this paper
• The spectrum of mutations, including four novel ones, in the thiamine‐responsive megaloblastic anemia gene SLC19A2 of eight families

  2000influential reference
• The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter

  1999influential reference
• Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness

  1999influential reference
• Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter.

  1999cited by this paper
• Human Placental Na+-dependent Multivitamin Transporter

  1999cited by this paper
• Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome

  1999influential reference
• Biotin-responsive basal ganglia disease: a novel entity.

  1998influential reference
• Principles governing amino acid composition of integral membrane proteins: application to topology prediction.

  1998influential reference
• Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate.

  1998cited by this paper
• Cloning and Functional Expression of a cDNA Encoding a Mammalian Sodium-dependent Vitamin Transporter Mediating the Uptake of Pantothenate, Biotin, and Lipoate*

  1998cited by this paper
• Clustering of mutations in the biotin-binding region of holocarboxylase synthetase in biotin-responsive multiple carboxylase deficiency.

  1996cited by this paper
• Faster linkage analysis computations for pedigrees with loops or unused alleles.

  1996cited by this paper
• [Cloning of the holocarboxylase synthetase cDNA and identification of mutations prevalent in Japanese HCS-deficient patients].

  1996cited by this paper
• Molecular analysis of holocarboxylase synthetase deficiency: a missense mutation and a single base deletion are predominant in Japanese patients.

  1995cited by this paper
• A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis

  1995cited by this paper
• Mutational hotspot in the human biotinidase gene causes profound biotinidase deficiency

  1995cited by this paper
• Avoiding recomputation in linkage analysis.

  1994cited by this paper
• Serial MRI in infantile bilateral striatal necrosis.

  1994cited by this paper
• Acute bilateral striatal necrosis in an infant: CT and MRI

  1994cited by this paper
• Isolation and characterization of mutations in the human holocarboxylase synthetase cDNA

  1994cited by this paper
• [Acute encephalopathy with symmetrical lesions of the thalamus, the putamen and the cerebellum on magnetic resonance imaging].

  1994cited by this paper
• Movement disorders in childhood organic acidurias. Clinical, neuroimaging, and biochemical correlations.

  1994cited by this paper
• Faster sequential genetic linkage computations.

  1993cited by this paper
• Bilateral striatal necrosis, dystonia and optic atrophy in two siblings.

  1992cited by this paper
• Acute bilateral striatal necrosis associated with Mycoplasma pneumoniae infection.

  1992cited by this paper
• MR findings in patients with subacute necrotizing encephalomyelopathy (Leigh syndrome): correlation with biochemical defect.

  1990cited by this paper
• Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia.

  1988cited by this paper
• Biotin Transport Through the Blood‐Brain Barrier

  1987cited by this paper
• Construction of human linkage maps: Likelihood calculations for multilocus linkage analysis

  1986cited by this paper
• Galactose-1-phosphate-uridyl transferase activity in chorionic villi: A first trimester prenatal diagnosis of galactosaemia

  1986cited by this paper
• Biotinidase deficiency: metabolites in CSF

  1986cited by this paper
• Neurologic symptoms of biotinidase deficiency

  1985cited by this paper
• Strategies for multilocus linkage analysis in humans.

  1984cited by this paper
• Easy calculations of lod scores and genetic risks on small computers.

  1984cited by this paper
• The biotin-dependent carboxylase deficiencies.

  1982cited by this paper
• Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease.

  1981cited by this paper
• The relationships of aging changes in the basal ganglia to manifestations of Huntington's chorea

  1980cited by this paper
• The biotin-dependent enzymes.

  1971cited by this paper

• Mouvements anormaux : dystonies génétiques

  2026cites this paper
• Transporters in vitamin uptake and cellular metabolism: impacts on health and disease

  2025cites this paper
• Structural insights into substrate binding of SLC19A3: Comparing inward-open and outward-open conformations.

  2025cites this paper
• Clinical and biochemical footprints of inherited metabolic diseases: Ia. Movement disorders, updated.

  2025cites this paper
• Structure‐based discovery of thiamine uptake inhibitors

  2025cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: Clinical Features, Treatment Response and Predictive Factors in a Cohort in a Tertiary Hospital

  2025cites this paper
• Inherited disorders of vitamin metabolism.

  2025cites this paper
• BIOCHEMICAL AND MEDICAL ASPECTS OF VITAMIN B1 RESEARCH.

  2025cites this paper
• The Path to Precision Medicine in Leigh Syndrome Spectrum: A Four-Decade Chronicle of Genetic Discovery and Targeted Treatment.

  2025cites this paper
• Precision diagnosis and treatment of vitamin metabolism-related epilepsy

  2024cites this paper
• SLC25A19 is a novel prognostic biomarker related to immune invasion and ferroptosis in HCC.

  2024cites this paper
• Biotin Homeostasis and Human Disorders: Recent Findings and Perspectives

  2024cites this paper
• Report of a novel recurrent homozygous variant c.620A>T in three unrelated families with thiamine metabolism dysfunction syndrome 5 and review of literature

  2024cites this paper
• Structural basis of substrate transport and drug recognition by the human thiamine transporter SLC19A3

  2024cites this paper
• Substrate transport and drug interaction of human thiamine transporters SLC19A2/A3

  2024cites this paper
• Mitochondrial disorder diagnosis and management- what the pediatric neurologist wants to know.

  2024cites this paper
• Medical magnetic resonance imaging publications in Arab countries: A 25-year bibliometric analysis

  2024cites this paper
• Structural basis of thiamine transport and drug recognition by SLC19A3

  2024cites this paper
• Primary mitochondrial disorders and mimics: Insights from a large French cohort

  2024cites this paper
• Biotin-thiamine responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of cases in Kuwait with novel variants

  2023cites this paper
• SLC25A19 Mutation-Related Bilateral Striatal Necrosis and Limbic System Involvement: A Case Report and Review of the Literature

  2023cites this paper
• Mechanisms underlying phenotypic variation in neurogenetic disorders

  2023cites this paper
• Vitamin B1 deficiency leads to high oxidative stress and mtDNA depletion caused by SLC19A3 mutation in consanguineous family with Leigh syndrome

  2023cites this paper
• Identification of epilepsy concomitant candidate genes recognized in Saudi epileptic patients.

  2022influential citation
• Disorders of Biotin Metabolism

  2022cites this paper
• Clinical and genetic studies of thiamine metabolism dysfunction syndrome-4: case series and review of the literature

  2022cites this paper
• Alzheimer’s disease is associated with disruption in thiamin transport physiology: A potential role for neuroinflammation

  2022cites this paper
• Case report: biotin-thiamine-responsive basal ganglia disease with severe subdural hematoma on magnetic resonance imaging

  2022cites this paper
• Next-generation sequencing of Tunisian Leigh syndrome patients reveals novel variations: impact for diagnosis and treatment

  2022cites this paper
• Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementation

  2022cites this paper
• Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia

  2022cites this paper
• Classification of Dystonia

  2022cites this paper
• Dietary Intake and Genetic Background Influence Vitamin Needs during Pregnancy

  2022cites this paper
• Early Infantile Thiamine Transporter-2 Deficiency with Epileptic Spasms—A Phenotypic Spectrum with a Novel Mutation

  2021cites this paper
• Report of the Largest Chinese Cohort With SLC19A3 Gene Defect and Literature Review

  2021cites this paper
• A Novel Variation in the Mitochondrial Complex I Assembly Factor NDUFAF5 Causes Isolated Bilateral Striatal Necrosis in Childhood

  2021cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease in Children: A Treatable Neurometabolic Disorder

  2021cites this paper
• Alcohol-Related Central Nervous System Disorders Associated with Vitamin B Deficiency

  2021cites this paper
• Clinical overview and phenomenology of movement disorders

  2021cites this paper
• Biotin-thiamine-responsive basal ganglia disease: A case report

  2021influential citation
• Biotin-thiamine responsive basal ganglia disease in the era of COVID-19 outbreak diagnosis not to be missed: A case report

  2021cites this paper
• Cofactors and Coenzymes | Biochemistry of Thiamine and Thiamine Phosphate Compounds

  2021cites this paper
• CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease

  2021cites this paper
• Systemic vitamin intake impacting tissue proteomes

  2020cites this paper
• Eleven novel mutations and clinical characteristics in seven Chinese patients with thiamine metabolism dysfunction syndrome.

  2020cites this paper
• Interference From High-Dose Biotin Intake in Immunoassays for Potentially Time-Critical Analytes by Roche: Evaluation of a Countermeasure for Worst-Case Scenarios.

  2020cites this paper
• Mapping the Diverse Genetic Disorders and Rare Diseases Among the Syrian Population: Implications on Refugee Health and Health Services in Host Countries

  2020cites this paper
• Treatable Inherited Movement Disorders in Children: Spotlight on Clinical and Biochemical Features

  2020cites this paper
• Thiamine

  2020cites this paper
• Serum growth differentiation factor 15 levels and clinical manifestations in patients with thiamine deficiency

  2020cites this paper
• Single gene, two diseases, and multiple clinical presentations: Biotin-thiamine-responsive basal ganglia disease.

  2020cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• Movement Disorders in Treatable Inborn Errors of Metabolism

  2019cites this paper
• Diagnosis and Management of Mitochondrial Disorders

  2019cites this paper
• Thiamine phosphokinase deficiency and mutation in TPK1 presenting as biotin responsive basal ganglia disease.

  2019cites this paper
• Neuroimaging Findings in Primary Mitochondrial Cytopathies

  2019cites this paper
• Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis.

  2019cites this paper
• Identification of Genetic Copy Number Variants in Neurodevelopmental Disorders from Genome Sequence Data

  2019cites this paper
• Spinozerebelläre Ataxien und hereditäre spastische Paraplegien bei Kindern und Jugendlichen

  2019cites this paper
• [Paroxysmal crying and motor regression for more than two months in an infant].

  2019cites this paper
• Effect of blood contamination of cerebrospinal fluid on amino acids, biogenic amines, pterins and vitamins

  2019cites this paper
• Biotin in metabolism, gene expression, and human disease

  2019cites this paper
• Genetic defects of thiamine transport and metabolism: A review of clinical phenotypes, genetics, and functional studies

  2019cites this paper
• Biotin attenuation of oxidative stress, mitochondrial dysfunction, lipid metabolism alteration and 7β-hydroxycholesterol-induced cell death in 158N murine oligodendrocytes

  2019cites this paper
• Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia

  2019cites this paper
• Genetic-Metabolic Disorders Presenting as Acute, but Reversible, Severe Epilepsies

  2018cites this paper
• Novel Homozygous Variant in TTC19 Causing Mitochondrial Complex III Deficiency with Recurrent Stroke-Like Episodes: Expanding the Phenotype.

  2018cites this paper
• Novel and de novo mutations in pediatric refractory epilepsy

  2018cites this paper
• Reduced thiamine binding is a novel mechanism for TPK deficiency disorder

  2018cites this paper
• Biotin Thiamin Responsive Basal Ganglia Disease in Siblings

  2018cites this paper
• Biotin-Thiamine-Responsive Basal Ganglia Disease: Case Report and Follow-Up of a Patient With Poor Compliance

  2018cites this paper
• Infantile neuroaxonale Dystrophie Seitelberger und Cockayne-Syndrom

  2018cites this paper
• Biotin-Thiamine Responsive Encephalopathy: Report of an Egyptian Family with a Novel SLC19A3 Mutation and Review of the Literature

  2018cites this paper
• Biotin–Thiamine Responsive Basal Ganglia Disease: A Treatable Metabolic Encephalopathy—Not to Be Missed!

  2018cites this paper
• Biotin: From Nutrition to Therapeutics.

  2017cites this paper
• Biotin‐thiamine responsive basal ganglia disease: Identification of a pyruvate peak on brain spectroscopy, novel mutation in SLC19A3, and calculation of prevalence based on allele frequencies from aggregated next‐generation sequencing data

  2017cites this paper
• Case 38-2017. A 20-Year-Old Woman with Seizures and Progressive Dystonia.

  2017cites this paper
• SLC19A3 (solute carrier family 19 (thiamine transporter), member 3)

  2017cites this paper
• TPK1 mutation induced childhood onset idiopathic generalized dystonia: Report of a rare mutation and effect of deep brain stimulation.

  2017cites this paper
• Disorders of vitamins and cofactors

  2017cites this paper
• Compound heterozygous SLC19A3 mutations further refine the critical promoter region for biotin-thiamine-responsive basal ganglia disease

  2017cites this paper
• SLC19A3 Gene Defects Sorting the Phenotype and Acronyms: Review

  2017cites this paper
• Thiamine metabolism is critical for regulating correlated growth of dendrite arbors and neuronal somata

  2017cites this paper
• The blood‐brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport

  2017cites this paper
• Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.

  2017cites this paper
• SLC19A3 related disorder: Treatment implication and clinical outcome of 2 new patients.

  2017cites this paper
• Pediatric multiple sclerosis mimics

  2017cites this paper
• 2016 William Allan Award: Human Disease Research: Genetic Cycling and Re-cycling.

  2017cites this paper
• Biotin–thiamine–responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment

  2017cites this paper
• Treatable mitochondrial diseases: cofactor metabolism and beyond.

  2017cites this paper
• Interaction of 2,4-Diaminopyrimidine–Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters

  2017cites this paper
• High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice

  2017cites this paper
• Psychological Assessment of Patients With Biotin-Thiamine-Responsive Basal Ganglia Disease

  2017cites this paper
• Amenable Treatable Severe Pediatric Epilepsies.

  2016cites this paper
• Selective accumulation of biotin in arterial chemoreceptors: requirement for carotid body exocytotic dopamine secretion

  2016cites this paper
• Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach

  2016cites this paper
• Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

  2016cites this paper
• Treatable Inborn Errors of Metabolism Due to Membrane Vitamin Transporters Deficiency

  2016cites this paper
• Leigh syndrome: One disorder, more than 75 monogenic causes

  2016cites this paper
• Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy

  2016cites this paper